Spirulina plantensis supplementation reduces anemia, inflammation and improve nutritional status of sickle cell aneamia patients
- Conditions
- Haematological Disorders
- Registration Number
- PACTR202211821139161
- Lead Sponsor
- PIEME Constant Anatole
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 140
Will be included in this study
1-Homozygote (SS) and heterozygote SC and SF
2- Male or female
3-Aged between 2 – 35 Years old
4- Patients who approve and sign the form
1-Sickle cell patient whose iron blood level is higher than normal
2-Sickle cell patient who is taking other treatment simultaneously
3- Sickle cell patient who decided to withdraw to the study
4- Sickle cell patient who did not go through the supplementation at least 3 three and half months
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.